Capstead Mortgage (CMO) EPS Estimated At $0.20, Partner Investment Management LP Has Boosted Biogen (BIIB) Holding By $312,715

July 17, 2017 - By Linda Rogers

Partner Investment Management Lp increased Biogen Inc (BIIB) stake by 9.34% reported in 2016Q4 SEC filing. Partner Investment Management Lp acquired 1,105 shares as Biogen Inc (BIIB)’s stock declined 13.45%. The Partner Investment Management Lp holds 12,933 shares with $3.67 million value, up from 11,828 last quarter. Biogen Inc now has $60.09B valuation. The stock increased 0.88% or $2.45 on July 14, reaching $280.81. About shares traded. Biogen Inc (NASDAQ:BIIB) has risen 4.94% since July 17, 2016 and is uptrending. It has underperformed by 11.76% the S&P500.

Analysts expect Capstead Mortgage Corporation (NYSE:CMO) to report $0.20 EPS on July, 26 after the close.They anticipate $0.01 EPS change or 5.26% from last quarter’s $0.19 EPS. CMO’s profit would be $19.35M giving it 13.05 P/E if the $0.20 EPS is correct. After having $0.20 EPS previously, Capstead Mortgage Corporation’s analysts see 0.00% EPS growth. The stock increased 0.77% or $0.08 on July 14, reaching $10.44. About shares traded. Capstead Mortgage Corporation (NYSE:CMO) has risen 6.72% since July 17, 2016 and is uptrending. It has underperformed by 9.98% the S&P500.

Capstead Mortgage Corporation operates as a self-managed real estate investment trust . The company has market cap of $1.01 billion. The Firm manages a leveraged portfolio of residential mortgage pass-through securities consisting of relatively short-duration adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac), or by an agency of the federal government, the Government National Mortgage Association (Ginnie Mae). It has a 15.97 P/E ratio. The Firm finances its residential mortgage investments by leveraging its long-term investment capital with secured borrowings consisting primarily of borrowings under repurchase arrangements with commercial banks and other financial institutions.

Among 4 analysts covering Capstead Mortgage (NYSE:CMO), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Capstead Mortgage had 10 analyst reports since August 3, 2015 according to SRatingsIntel. Wells Fargo downgraded Capstead Mortgage Corporation (NYSE:CMO) on Monday, April 11 to “Market Perform” rating. Wells Fargo upgraded the stock to “Outperform” rating in Wednesday, May 11 report. On Friday, July 31 the stock rating was maintained by Deutsche Bank with “Hold”. The firm has “Buy” rating given on Friday, July 31 by Maxim Group. Keefe Bruyette & Woods maintained it with “Hold” rating and $1100 target in Monday, May 29 report. The stock of Capstead Mortgage Corporation (NYSE:CMO) earned “Sell” rating by M Partners on Tuesday, August 11. As per Friday, January 29, the company rating was maintained by Maxim Group. Wells Fargo downgraded Capstead Mortgage Corporation (NYSE:CMO) on Tuesday, February 7 to “Market Perform” rating.

Investors sentiment decreased to 1 in 2016 Q4. Its down 0.14, from 1.14 in 2016Q3. It dropped, as 20 investors sold Capstead Mortgage Corporation shares while 57 reduced holdings. 20 funds opened positions while 57 raised stakes. 62.58 million shares or 2.11% more from 61.29 million shares in 2016Q3 were reported. Goldman Sachs Grp owns 204,350 shares or 0% of their US portfolio. First Manhattan reported 281 shares. Thompson Davis Incorporated accumulated 1,500 shares. 35,922 are owned by Pub Employees Retirement Association Of Colorado. Van Eck Assocs accumulated 307,244 shares. Bank & Trust Of Ny Mellon reported 1.14M shares. State Of New Jersey Common Pension Fund D stated it has 0.01% in Capstead Mortgage Corporation (NYSE:CMO). Massachusetts-based Wellington Gru Llp has invested 0% in Capstead Mortgage Corporation (NYSE:CMO). 22,520 were reported by Two Sigma Lc. Maple Capital Mgmt holds 0.15% of its portfolio in Capstead Mortgage Corporation (NYSE:CMO) for 47,675 shares. 716,954 were reported by Principal Fincl Grp. Capital Fund Mgmt has 0% invested in Capstead Mortgage Corporation (NYSE:CMO) for 43,900 shares. Deutsche Savings Bank Ag, a Germany-based fund reported 203,405 shares. Next Gru stated it has 0% in Capstead Mortgage Corporation (NYSE:CMO). Smith Graham Inv Advsrs Limited Partnership reported 0.67% of its portfolio in Capstead Mortgage Corporation (NYSE:CMO).

Investors sentiment decreased to 0.92 in Q4 2016. Its down 0.08, from 1 in 2016Q3. It turned negative, as 90 investors sold BIIB shares while 341 reduced holdings. 93 funds opened positions while 304 raised stakes. 183.23 million shares or 1.51% less from 186.04 million shares in 2016Q3 were reported. Mai Capital Mngmt has 4,166 shares for 0.09% of their portfolio. Sequoia Finance Advsrs Limited Liability Company, a Ohio-based fund reported 10,154 shares. Bb&T Corporation owns 5,650 shares or 0.03% of their US portfolio. Pensionfund Dsm Netherlands has 0.64% invested in Biogen Inc (NASDAQ:BIIB) for 15,500 shares. Tfs Limited Co has 1,642 shares. First Commercial Bank Of Omaha reported 0.39% stake. Bbva Compass Bank & Trust stated it has 4,529 shares or 0.09% of all its holdings. Tocqueville Asset Mngmt Ltd Partnership has 0.42% invested in Biogen Inc (NASDAQ:BIIB) for 116,274 shares. Prelude Capital Management Limited Co accumulated 0.14% or 4,214 shares. Hudock Ltd Liability Corp holds 100 shares or 0.02% of its portfolio. Keybank Natl Association Oh holds 0.03% or 15,058 shares in its portfolio. Meridian Management invested 1.6% of its portfolio in Biogen Inc (NASDAQ:BIIB). Endurant Mgmt LP reported 1.12% in Biogen Inc (NASDAQ:BIIB). Moreover, Acadian Asset Mgmt Limited Liability Company has 0.01% invested in Biogen Inc (NASDAQ:BIIB). Amalgamated Retail Bank invested in 23,701 shares or 0.3% of the stock.

Among 23 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Biogen Idec Inc. had 48 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Buy” rating by H.C. Wainwright on Tuesday, August 11. The stock of Biogen Inc (NASDAQ:BIIB) has “Hold” rating given on Monday, June 12 by Jefferies. The firm has “Hold” rating given on Thursday, June 1 by BMO Capital Markets. As per Thursday, December 29, the company rating was maintained by Raymond James. Bernstein initiated the stock with “Outperform” rating in Wednesday, June 29 report. The company was maintained on Wednesday, October 7 by RBC Capital Markets. As per Monday, July 27, the company rating was maintained by Argus Research. On Friday, December 9 the stock rating was maintained by Stifel Nicolaus with “Hold”. The company was initiated on Thursday, January 7 by Standpoint Research. Morgan Stanley maintained the shares of BIIB in report on Wednesday, June 14 with “Hold” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: